1Boldt,J. , Haisch G. ,Suttner S,et al. Effects of a new modified,balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anesth 2002,89:722-728.
2Roten V, Madjdpour C, Frascarolo P, et al. Molar substitution and C2/C6ratio of hydroxyethyl starch:influence on blood coagulation. Br J Anaesth,2006,96:455 - 463.
3Boldt J,Brenner T, Lehmann A, et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch reparation with gelatin. Intensive Care Med,2003 ,29(5):763-769.
4JamnickiM, ZollingerA. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0. 4 and hydroxyethyl starch 200/0. 5 using thrombelastography. Anesth Analg, 1998,87(5) :989-993.
5Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelast ometry coagulati on analysis. ActaAnaesthesiol Stand, 2005,49 (3) : 373 - 378.
6Jungheinrieh C, Sauermann W, Beperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0. 4(6%) with an optimised in vivo molecularweight in orthopadeic surgery: a randomized, double blindstudy. Drugs RD,2004,5(1) :1-9.
7Moretti EW, Roberts on K M, et al. I ntraoperative coil old ad ministration reduces postoperative nausea and vomiting and improve spostoperative outcomes compared with erystalloid administration. J An Ana,2003,96(2):611-617.
8Wilkes N J, Woolf RF, Mutch MR, et al. The Effects of Balanced Versus Saline--Based Hetastarch and Crystalloid Solutions on Acid-- Base and Electrolyte Status and Gastric Mucosal Perfusion in Elderly Surgical Patients. Anesth Analg,2001,93:811-816.
9Toraman F, Evrenkaya S, Yuce M, et al. Lactric acidosis after cardiac surgery is association with adverse outcome. Heart Surg Forum, 2004,7 : E155- 159.
6Zarychanski R,Abou-Setta AM,Turgeon AF,et al.Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation:a systematic review and meta-analysis[J].JAMA,2013,309(7):1 229.
7Haase N,Perner A,Hennings LI,et al.Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis:systematic review with meta-analysis and trial sequential analysis[J].BMJ,2013(15):346.
8Perner A,Haase N,Guttormsen AB,et al.Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis[J].N Engl J Med,2012,367(2):124.
9FDA.Hydroxyethyl starch solutions:FDA safety communication-boxed warning on increased mortality and severe renal injury and risk of bleeding[EB/OL].[2013-06-24].http://www.fda.gov/Safety/MedW atch/Safety Information/Safety Alertsfor Human Medical Products/ucm358349.html.
